We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Image: Device schematic and experimental workflow (Williams, E.K., Zhang, D.Y., Alese, T.T. et al. Nature Biomedical Engineering, 2026. https://doi.org/10.1038/s41551-026-01818-0)

Microfluidic Assay Predicts Treatment Response in Pediatric Leukemia

A new lab-on-a-chip assay profiles responses to three-drug combinations in pediatric leukemia. More...
29 Oct 2026
Image: The clinical study evaluated whether small RNA biomarkers could help predict survival outcomes in patients with locally advanced, non-resectable stage III lung cancer. (Image Credit: Shutterstock)

Blood-Based Small RNA Assay Predicts Survival After Lung Cancer Treatment

Hummingbird Diagnostics presented findings on biomarkers for lung cancer treatment monitoring at ESMO Congress 2026. More...
29 Oct 2026
Image Credit: Adobe Stock

AI Models Use Routine Blood Tests and Health Records to Predict Cancer Risk

An AI approach using routine blood tests and clinical history predicts risk of multiple cancers. More...
29 Oct 2026
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

Agendia presented validation data for an AI-driven digital pathology approach based on the MammaPrint 70-gene signature. More...
29 Oct 2026
Image: AlloSure Kidney measures donor-derived cell-free DNA (dd-cfDNA) to assess graft injury, while AlloSure Plus combines the AlloSure result with additional clinical parameters. (Photo of CareDx)

Donor-Derived DNA Testing May Reduce Biopsies in Kidney Transplant Monitoring

New data show a dd-cfDNA test predicts adverse graft outcomes and cuts surveillance biopsies in kidney transplants. More...
29 Oct 2026
Image: The approach analyzes tumor-derived DNA fragments in CSF collected by lumbar puncture, assessing individual gene changes and broader tumor-associated DNA patterns. (Image Credit: Adobe Stock)

Spinal Fluid Liquid Biopsy May Help Clarify Uncertain Brain Tumor Findings

A new CSF cell-free DNA test clarifies brain/spinal tumor diagnoses when MRI is equivocal or biopsy is unsafe. More...
28 Oct 2026
Image: Cytokine release syndrome (CRS) can occur following CAR T-cell therapy in patients with autoimmune disease. (Image Credit: Shutterstock)

Immune and Inflammatory Markers May Help Assess CAR T-Cell Complication Risk

New data link immune cell levels and inflammation to complication risk after CAR T-cell therapy for autoimmune disease. More...
28 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Copyright © 2000-2026 Globetech Media. All rights reserved.